Table 4.
Virus | Titer in exposure, PFU/ml | Host organism | Maintenance/growth conditions |
---|---|---|---|
Enveloped viruses | |||
Mammalian viruses | |||
SARS-CoV-2 | 5 × 105 | Vero E6 cells (Growth medium: DMEM, 10% heat-inactivated FBS, 100 U/ml penicillin and 100 μg/ml streptomycin; grown at 37 °C and 5% CO2) | Virus growth medium: DMEM, 0.2% BSA, 100 U/ml penicillin, 100 μg/ml streptomycin |
TGEV | 8.35 × 106 | ST cells (Growth medium: DMEM, 10% heat-inactivated FBS, 100 U/ml penicillin and 100 μg/ml streptomycin, 37 °C 5% CO2) | Virus growth medium: DMEM, 0.2% BSA, 100 U/ml penicillin and 100 μg/ml streptomycin |
Influenza virus A/WSN/1933 | 6.65 × 104 | MDCK-2 cells (Growth medium: DMEM, 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin, 37 °C 5% CO2) | Virus growth medium: DMEM, 0.2% BSA, 100 U/ml penicillin and 100 μg/ml streptomycin, 1 µg/ml TPCK-treated trypsin |
Bacteriophages | |||
ɸ6 | 1 × 107 | Pseudomonas sp. (Growth medium Tryptone Soy Broth TSB: 17 g/l casein peptone, 3 g/l soy peptone, 2.5 g/l glycose, 5 g/l NaCl, 2.5 g/l K2HPO4; 25 °C; for solid medium 15 g/l agar was added) |
Phage maintenance medium: SM buffer (0.1 M NaCl, 8 mM MgSO4, 50 mM Tris–HCl; pH 7.5 Semisolid TSB top agar used for infection: 7 g/l agar added to TSB |
Non-enveloped viruses | |||
Mammalian viruses | |||
EMCV | 2.5 × 107 | BHK-21 cells (Growth medium: GMEM, 10% heat-inactivated FBS, 2% TPB, 2% 1 M Hepes (pH 7.2), 100 U/ml penicillin, 100 μg/ml streptomycin, 37 °C 5% CO2) | Virus growth medium: GMEM, 0.2% BSA, 2% 1 M Hepes (pH 7.2), 100 U/ml penicillin, 100 μg/ml streptomycin |
Bacteriophages | |||
MS2 | 1 × 107 | Escherichia coli (Growth medium NZCYM broth: 10 g/l casein hydrolysate, 5 g/l NaCl, 1 g/l casamino acids, 5 g/l yeast extract, 2 g/l MgSO4·7H2O, 2 g/l maltose 37 °C; for solid medium 15 g/l agar was added) |
Phage maintenance medium: SM buffer (see above) Semisolid NZCYM top agar used for infection: 7 g/l agar added to NZCYM |